 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/22/2024 |
$5.07 |
$5.25 |
$4.72 |
$5.00 |
95.90K | | 04/23/2024 |
$5.08 |
$5.46 |
$5.08 |
$5.35 |
22.00K | | 04/24/2024 |
$5.36 |
$5.43 |
$4.87 |
$4.88 |
65.50K | | 04/25/2024 |
$4.88 |
$4.99 |
$4.56 |
$4.88 |
71.10K | | 04/26/2024 |
$5.05 |
$5.19 |
$4.88 |
$5.03 |
48.60K |
|
|
| Affimed is a clinical-stage immuno-oncology company focused on discovering and developing targeted cancer immunotherapies. Co.'s main candidate, AFM13, is an innate cell engager (ICE®) designed for the treatment of certain CD30-positive malignancies, including for both Hodgkin lymphoma and certain non-Hodgkin lymphomas. Co.'s second candidate, AFM24, is designed to address limitations, such as toxicities or treatment resistance, associated with existing therapeutic anti-epidermal growth factor receptor monoclonal antibodies. Co.'s third wholly-owned ICE® molecule, AFM28, was developed from its ROCK® platform and is designed to bind to CD123, an established target in myeloid malignancies. | |
|
Affimed N.V. (AFMD) has the following price history information. Looking back at AFMD historical stock prices for the last five trading days, on April 22, 2024, AFMD opened at $5.07, traded as high as $5.25 and as low as $4.72, and closed at $5.00. Trading volume was a total of 95.90K shares. On April 23, 2024, AFMD opened at $5.08, traded as high as $5.46 and as low as $5.08, and closed at $5.35. Trading volume was a total of 22.00K shares. On April 24, 2024, AFMD opened at $5.36, traded as high as $5.43 and as low as $4.87, and closed at $4.88. Trading volume was a total of 65.50K shares. On April 25, 2024, AFMD opened at $4.88, traded as high as $4.99 and as low as $4.56, and closed at $4.88. Trading volume was a total of 71.10K shares. On April 26, 2024, AFMD opened at $5.05, traded as high as $5.19 and as low as $4.88, and closed at $5.03. Trading volume was a total of 48.60K shares.
AFMD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Affimed N.V. shares, starting with a $10,000 purchase of AFMD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/15/2014 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$64.00 |
|
| End price/share: |
$5.03 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-92.14% |
|
| Average Annual Total Return: |
-23.23% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$786.39 |
|
| Years: |
9.62 |
|
|
|
| Date |
Close |
| 04/22/2024 | $5.00 | | 04/23/2024 | $5.35 | | 04/24/2024 | $4.88 | | 04/25/2024 | $4.88 | | 04/26/2024 | $5.03 |
|
|
